Search by Drug Name or NDC
NDC 70069-0811-25 PHENYLEPHRINE HYDROCHLORIDE 10 mg/mL Details
PHENYLEPHRINE HYDROCHLORIDE 10 mg/mL
PHENYLEPHRINE HYDROCHLORIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 70069-0811 |
|---|---|
| Product ID | 70069-811_18b65b44-fdd1-4385-b6f8-cf3cbdc8d0e6 |
| Associated GPIs | |
| GCN Sequence Number | 005068 |
| GCN Sequence Number Description | phenylephrine HCl VIAL 10 MG/ML INJECTION |
| HIC3 | J5E |
| HIC3 Description | SYMPATHOMIMETIC AGENTS |
| GCN | 20310 |
| HICL Sequence Number | 002087 |
| HICL Sequence Number Description | PHENYLEPHRINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | PHENYLEPHRINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PHENYLEPHRINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213318 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0811-25 (70069081125)
| NDC Package Code | 70069-811-25 |
|---|---|
| Billing NDC | 70069081125 |
| Package | 25 VIAL in 1 CARTON (70069-811-25) / 1 mL in 1 VIAL (70069-811-01) |
| Marketing Start Date | 2023-07-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |